C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2006
11/30/2006	WO2006126263A1 Vhl peptide
11/30/2006	WO2006126236A1 Liver progenitor cells
11/30/2006	WO2006126219A1 Liver progenitor cells
11/30/2006	WO2006125980A2 Apparatus for communicating with a memory tag and use of the same
11/30/2006	WO2006125321A1 Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal
11/30/2006	WO2006125310A1 Methods for producing microspore derived doubled haploid apiaceae
11/30/2006	WO2006108234A8 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor
11/30/2006	WO2006099698A3 Novel anti-plgf antibody
11/30/2006	WO2006093858A3 Method and composition for treating diabetes
11/30/2006	WO2006091892A3 Methods of producing recombinant proteins
11/30/2006	WO2006084226A3 Antibodies that bind to epha2 and methods of use thereof
11/30/2006	WO2006078782A9 Compositions containing agm cells and methods of use thereof
11/30/2006	WO2006046148A3 Rna constructs
11/30/2006	WO2006018205A3 Novel essential genes of bacillus licheniformis and improved biotechnical production method based thereon
11/30/2006	WO2005039488A3 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential
11/30/2006	WO2005001042A8 Smooth muscle progenitor cells
11/30/2006	WO2003016477A3 Insect or83b odorant receptor
11/30/2006	US20060272060 Transgenic plants having improved tolerance to abiotic stress such as drought, shade, cold, heat and low nitrogen conditions; member of the SCARECROW family
11/30/2006	US20060272059 Use of zinc finger transcription factor zpt2-3 to generate plants with increased desiccation tolerance
11/30/2006	US20060272058 Seed preferred regulatory elements
11/30/2006	US20060272057 Methods for improving crop plant architecture and yield
11/30/2006	US20060272056 Plant 1-deoxy-D-xylulose 5-phosphate synthase
11/30/2006	US20060272055 Expression vector comprising nucleotide sequences coding glycosyltransferase for enhancing cellulose, hemicellulose, and pectin concentration in transgenic corn
11/30/2006	US20060272054 Altering cellulose synthase levels in plants; transgenic plants; for modulating, in a transgenic plant, expression of the nucleic acids
11/30/2006	US20060272053 Regular white rice, Oryza sativa japonica cv. Hwa-Young, was transformed with maize C1 and R-S regulatory genes each under control of endosperm-specific promoter; flavonoids are highly concentrated in 4-5 layers of outer endosperm, and moderate level of flavonoids was also detected in inner endosperm
11/30/2006	US20060272051 hybridization of first and second transgenic parental plant, hybridization generating a genetic endowment in F1 seed for production by combining in F1 seed first and second partial genetic endowments of first and second transgenic parental plants, followed by isolating product of interest from F1 seed
11/30/2006	US20060272050 Polypeptides having antimicrobial activity and polynucleotides encoding same
11/30/2006	US20060272049 Insect resistance using inhibition of gene expression
11/30/2006	US20060272048 Soybean seeds and plants exhibiting natural herbicide resistance
11/30/2006	US20060272046 Used to modulate the phytic acid biosynthesis in such a way as to decrease phytate and/or increase non-phytate phosphorous, especially in corn or soy animal feedstuffs
11/30/2006	US20060272045 Brittle-2 regulatory elements for use in plants
11/30/2006	US20060272044 Methods for Improving a Photosynthetic Carbon Fixation Enzyme
11/30/2006	US20060272042 designated J-101 and having representative seed deposited with American Type Culture Collection (ATCC) with Accession No. PTA-4814;
11/30/2006	US20060272038 Transgenic Alzheimer's mouse model vectors and uses thereof
11/30/2006	US20060272037 Millisecond activation switch for seven-transmembrane proteins
11/30/2006	US20060272036 Ruminant mhc class-i-like fc receptors
11/30/2006	US20060271201 Porous ceramic structure containing biologics
11/30/2006	US20060270838 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders
11/30/2006	US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha
11/30/2006	US20060270645 Agents and methods for enhancing bone formation
11/30/2006	US20060270621 Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs
11/30/2006	US20060270555 Root nodule bacteria having enhanced nitrogen-fixation ability
11/30/2006	US20060270042 High-titer retroviral packaging cells
11/30/2006	US20060270041 Cell lines for production of replication-defective adenovirus
11/30/2006	US20060270040 Compositions and methods for treating tissue
11/30/2006	US20060270038 Dry powder cell culture products containing lipid and methods of production thereof
11/30/2006	US20060270037 Collagen-coated carrier and method for manufacturing collagen-coated carrier
11/30/2006	US20060270036 bioreactors comprising a flexible bag container and a rotational assembly in sealed cooperation with an opening of the container, comprising a rotation wheels adapted to receive and releasably couple with drive shafts; used for agitating the cell cultures
11/30/2006	US20060270035 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by WNT factors
11/30/2006	US20060270034 Methods of culturing embryonic stem cells and controlled differentiation
11/30/2006	US20060270033 Composition containing gamete or embryo and animal white yolk and the use thereof
11/30/2006	US20060270032 Microscale micropatterened engineered in vitro tissue
11/30/2006	US20060270031 Cell separation method and kit using phase separation
11/30/2006	US20060270030 Multimodally altered cells as a form for administering active substances and as diagnostic particles
11/30/2006	US20060270029 Automatable artificial immune system (AIS)
11/30/2006	US20060270028 Vessel comprising biological scaffold and which utilizes oscillating motion in propagation of preferential tissues; regenerative medicine
11/30/2006	US20060270023 Three-dimentioal, flexible cell growth substrate and related methods
11/30/2006	US20060270002 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270001 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270000 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060269996 Human voltage gated sodium channel beta1A subunit and methods of use
11/30/2006	US20060269995 Novel assays utilizing nicotinic acetylcholine receptor subunits
11/30/2006	US20060269992 Producing a first thioredoxin polypeptide comprising thioredoxin, a modified thioredoxin, or a truncated thioredoxin; andincubating the first thioredoxin polypeptide with a protein-binding dye to form a first stained molecular weight marker
11/30/2006	US20060269989 Process for producing antibodies
11/30/2006	US20060269977 Recombinant antibody recognizing dioxin and gene encoding the antibody
11/30/2006	US20060269973 Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
11/30/2006	US20060269959 Sequences of an Ih ion channel and use thereof
11/30/2006	US20060269954 Self-assembling recombinant papillomavirus capsid proteins
11/30/2006	US20060269940 Normalized nucleic acid libraries and methods of production thereof
11/30/2006	US20060269938 Polynucleotides encoding insect plasma membrane ca2+ ATPase and uses thereof
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269908 resuspension in a freezing medium and slow cooling at a controlled rate; useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products, and as targets for the discovery of factors or molecules that can affect them
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269557 Humanized anti-prostate stem cell antigen monoclonal antibody
11/30/2006	US20060269555 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders
11/30/2006	US20060269550 Anti-ghrelin fab antibodies
11/30/2006	US20060269548 Lymphatic endothelial cells materials and methods
11/30/2006	US20060269545 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
11/30/2006	US20060269543 Compositions and methods for increasing the stability of antibodies
11/30/2006	US20060269541 S.agalactiae antigens I + II
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269529 Modified t lymphocytes and uses therefor
11/30/2006	US20060269528 Production detection and use of transformant cells
11/30/2006	US20060269527 Isolation of cells from bone
11/30/2006	US20060269526 Stromal antigen-presenting cells and use thereof
11/30/2006	US20060269519 Modulation of cytokine signaling regulators and applications for immunotherapy
11/30/2006	DE102006012162A1 Knochen Reparaturmaterial unter Verwendung einer Knorpelzelle mit dem Potenzial für Hypertrophie und ein Gerüst Bone repair material using a cartilage cell with the potential for hypertrophy and a scaffold
11/30/2006	CA2610017A1 Compositions and methods for treating tissue
11/30/2006	CA2609937A1 Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal
11/30/2006	CA2609849A1 Chondrogenic compositions and methods of use
11/30/2006	CA2609701A1 Compositions and methods for enhancing axon regeneration
11/30/2006	CA2609523A1 Liver progenitor cells
11/30/2006	CA2609361A1 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
11/30/2006	CA2609164A1 Gene of transporter selective to mugineic acid-iron complex
11/30/2006	CA2609145A1 Microscale micropatterned engineered in vitro tissue
11/30/2006	CA2607852A1 Transgenic alzheimer's mouse model vectors and uses thereof
11/30/2006	CA2602434A1 Dendritic cell compositions and methods
11/30/2006	CA2545557A1 Stromal antigen-presenting cells and use thereof
11/29/2006	EP1726656A2 Metalloproteinase-disintegrin family members: SVPH DNAs and polypeptides
11/29/2006	EP1726655A1 Beta fructofuranosidase mutant

1 ... 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 ... 1827